ASCENDIS PHARMA, INC.

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$3.5M

Filings

Firms Hired

Active Period

2020–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$590,000	6	2
2025	$650,000	8	2
2024	$540,000	10	2
2023	$590,000	8	2
2022	$570,000	8	2
2021	$500,000	8	2
2020	$110,000	6	2

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ASCENDIS PHARMA, INC.	$3,550,000	26
RUBICON ADVISORS, LLC	—	28

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Food & Drug Administration (FDA)	29
HOUSE OF REPRESENTATIVES	9
SENATE	8
Natl Institutes of Health (NIH)	3

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	40
Health Issues	Health Issues	2

Source: Senate LDA

ASCENDIS PHARMA, INC. — Lobbying Disclosure | Poliscope